Disclosure of Other Information Sample Clauses

Disclosure of Other Information. I understand that CPEX will not require nor expect me to disclose to CPEX, or to use at or for CPEX, any secret or confidential information that I obtained from any of my former employers which is not then publicly available, and I agree not to use at or for CPEX any such secret or confidential information; provided, however, that the foregoing obligation shall not apply to confidential information related to the drug delivery business of Bentley Pharmaceuticals, Inc. (“Bentley”) and is subsequently transferred to CPEX upon the spin-off of CPEX to the stockholders of Bentley.
Sample 1Sample 2Sample 3
AutoNDA by SimpleDocs
Disclosure of Other Information. Subject to Section 3.3.7.3, below, JHU, from time to time, but no less often than once each Calendar Quarter, during the Sponsored Research Term (including any extensions thereof), shall disclose to GI (x) any Factor Rights (other than the cDNA sequences promptly disclosed under Section 3.3.7.1, above) and (y) any Data which relates to the Sponsored Research. GI may, at its sole option, either (i) disclose toMetaMorphix or (ii) require JHU to disclose toMetaMorphix. any such Factor Rights and Data which relates to one or more of the BMPs, GDFs or Collaborative Factors that have not yet become either a GI Factor or a MetaMorphix Factor in accordance with the selection process set forth in Article 5 below, PROVIDED, HOWEVER, that JHU shall not disclose any such Factor Rights or Data to MetaMorphix without GI's prior consent, which consent shall not be unreasonably withheld. Notwithstanding the foregoing, upon GI's request, which request may be made from time to time, JHU shall promptly (within fourteen (14) days of such request) disclose to GI all such Factor Rights and Data which JHU has not previously disclosed to GI. Notwithstanding the foregoing. JHU agrees that it will not disclose to MetaMorphix any Factor Rights or Data pertaining to any GI Factor (after such Factor has been selected by GI in accordance with Article 5 hereof) or to any Additional Factor without GI's prior written consent. which consent may be provided or withheld in GI's sole discretion.
Sample 1Sample 2
Disclosure of Other Information. Each Party shall promptly report and disclose to the other Parties, in writing, the applicable (x) Factor Rights developed in conducting the Original Research and (y) Data developed in conducting the Original Research as follows:
Sample 1Sample 2
Disclosure of Other Information. Each Party shall promptly report and disclose to the other Parties, in writing, the applicable (x) Factor Rights developed in conducting the Original Research and (y) Data developed in conducting the Original Research as follows: in connection with the preparation, filing and maintenance by a Party of a Patent covering such Factor Rights, or a review of information by the Parties prior to public disclosure, the disclosure of such Factor Rights and Data may be limited to that Factor (or those Factors) which is (are) the subject of the Patent action or public disclosure: and
Sample 1
Disclosure of Other Information. I understand that CPEX will not require nor expect me to disclose to CPEX, or to use at or for CPEX, any secret or confidential information that I obtained from any of my former employers which is not then publicly available, and I agree not to use at or for CPEX any such secret or confidential information.
Sample 1
Disclosure of Other Information. The Parties agree that Millennium may disclose to any potential New Commercial Licensee any information and documents within its possession or control concerning the Development, Commercialization and Manufacture of INTEGRILIN Products in or for the Transferring Territory, including without limitation those which contain Millennium and/or Schering Confidential Information; provided that Millennium has first entered into a confidentiality agreement with such potential New Commercial Licensee. Any such confidentiality agreement shall obligate the potential New Commercial Licensee to treat all such information and documents as confidential, not to disclose the information and documents to any Third Party (other than its agents or advisors who are bound by similar confidentiality obligations), and to use the information and documents solely for the purpose of evaluating its interest in entering into a New Commercial Agreement. The duration of the confidentiality and non-use obligations under such confidentiality agreement shall be for a reasonable and customary period of time (in no case less than a period of five (5) years) to be agreed upon by Millennium and the potential New Commercial Licensee.
Sample 1

Related to Disclosure of Other Information

  • Disclosure of Financial Information Lender is hereby authorized to disclose any financial or other information about Guarantor to any governmental authority having jurisdiction over Lender or to any present, future or prospective participant or successor in interest in the Notes. The information provided may include, without limitation, amounts, terms, balances, payment history, return item history and any financial or other information about Guarantor.

  • Disclosure of Material Information The Company covenants and agrees that neither it nor any other person acting on its behalf has provided or will provide any Purchaser or its agents or counsel with any information that the Company believes constitutes material non-public information, unless prior thereto such Purchaser shall have executed a written agreement regarding the confidentiality and use of such information. The Company understands and confirms that each Purchaser shall be relying on the foregoing representations in effecting transactions in securities of the Company.

  • Disclosure of Transactions and Other Material Information The Company shall, within the time required under the 1934 Act, file a Current Report on Form 8-K describing all the material terms of the transactions contemplated by the Transaction Documents in the form required by the 1934 Act and attaching all the material Transaction Documents (including, without limitation, this Agreement (including all attachments, the “8-K Filing”). From and after the filing of the 8-K Filing, the Company shall have disclosed all material, non-public information (if any) delivered to any of the Buyers by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees or agents in connection with the transactions contemplated by the Transaction Documents. In addition, effective upon the filing of the 8-K Filing, the Company acknowledges and agrees that any and all confidentiality or similar obligations under any agreement with respect to the transactions contemplated under the Transaction Documents, whether written or oral, between the Company, any of its Subsidiaries or any of their respective officers, directors, affiliates, employees or agents, on the one hand, and any of the Buyers or any of their affiliates, on the other hand, shall terminate. In the event of a breach of any of the foregoing covenants by the Company, any of its Subsidiaries, or any of its or their respective officers, directors, employees and agents (as determined in the reasonable good faith judgment of such Buyer), in addition to any other remedy provided herein or in the Transaction Documents, such Buyer shall have the right to make a public disclosure, in the form of a press release, public advertisement or otherwise, of such material, non-public information, as applicable, without the prior approval by the Company, any of its Subsidiaries, or any of its or their respective officers, directors, employees or agents; provided the Buyer shall have first provided written notice to the Company that it believes it has received information that constitutes material, non-public information, the Company shall have at least 48 hours to publicly disclose such material, non-public information prior to any such disclosure by the Buyer or demonstrate to the Buyer in writing why such information does not constitute material, non-public information, and (assuming the Buyer and Buyer’s counsel disagree with the Company’s determination) the Company shall have failed to publicly disclose such material, non-public information within such time period. No Buyer shall have any liability to the Company, any of its Subsidiaries, or any of its or their respective officers, directors, employees, stockholders or agents, for any such disclosure. To the extent that the Company delivers any material, non-public information to a Buyer without such Buyer’s consent, the Company hereby covenants and agrees that such Buyer shall not have any duty of confidentiality with respect to, or a duty not to trade on the basis of, such material, non-public information. Subject to the foregoing, neither the Company, its Subsidiaries nor any Buyer shall issue any press releases or any other public statements with respect to the transactions contemplated hereby; provided, however, the Company shall be entitled, without the prior approval of any Buyer, to make any press release or other public disclosure with respect to such transactions (i) in substantial conformity with the 8-K Filing and contemporaneously therewith and (ii) as is required by applicable law and regulations (provided that in the case of clause (i) each Buyer shall be consulted by the Company in connection with any such press release or other public disclosure prior to its release). Notwithstanding anything contained in this Agreement to the contrary and without implication that the contrary would otherwise be true, the Company expressly acknowledges and agrees that no Buyer has had, and no Buyer shall have (unless expressly agreed to by a particular Buyer after the date hereof in a written definitive and binding agreement executed by the Company and such particular Buyer (it being understood and agreed that no Buyer may bind any other Buyer with respect thereto)), any duty of confidentiality with respect to, or a duty not to trade on the basis of, any material, non-public information regarding the Company or any of its Subsidiaries.

  • Disclosure of Information Holder is aware of the Company’s business affairs and financial condition and has received or has had full access to all the information it considers necessary or appropriate to make an informed investment decision with respect to the acquisition of this Warrant and its underlying securities. Holder further has had an opportunity to ask questions and receive answers from the Company regarding the terms and conditions of the offering of this Warrant and its underlying securities and to obtain additional information (to the extent the Company possessed such information or could acquire it without unreasonable effort or expense) necessary to verify any information furnished to Holder or to which Holder has access.

  • Further Information Prior to the Closing Date, the Company shall have furnished to the Representative such further information, certificates and documents as the Representative may reasonably request.

  • Information The Buyer and its advisors, if any, have been, and for so long as the Note remain outstanding will continue to be, furnished with all materials relating to the business, finances and operations of the Company and materials relating to the offer and sale of the Securities which have been requested by the Buyer or its advisors. The Buyer and its advisors, if any, have been, and for so long as the Note remain outstanding will continue to be, afforded the opportunity to ask questions of the Company. Notwithstanding the foregoing, the Company has not disclosed to the Buyer any material nonpublic information and will not disclose such information unless such information is disclosed to the public prior to or promptly following such disclosure to the Buyer. Neither such inquiries nor any other due diligence investigation conducted by Buyer or any of its advisors or representatives shall modify, amend or affect Buyer’s right to rely on the Company’s representations and warranties contained in Section 3 below. The Buyer understands that its investment in the Securities involves a significant degree of risk. The Buyer is not aware of any facts that may constitute a breach of any of the Company's representations and warranties made herein.

  • Disclosure of Confidential Information Any Finance Party may disclose:

  • Nondisclosure of Information To the extent necessary for the execution of this Agreement or to satisfy the requirements for disclosure to participants or to meet the requirements of Sections 8 and 9, the Advisor shall keep in strict confidence all information about the financial affairs of the Subaccount. The Advisor may include information about the Subaccount in aggregate information provided by the Advisor as long as the information is not set out separately or in any other manner that would enable a third party to determine the financial affairs of the Subaccount.

  • Other Information Such other information respecting the business, condition (financial or otherwise), operations, performance, properties or prospects of any Loan Party or any of its Subsidiaries as any Agent, or any Lender Party through the Administrative Agent, may from time to time reasonably request.

  • Other Financial Information Budgets, sales projections, operating plans and other financial information reasonably requested by Bank.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!